BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8509998)

  • 21. Effect of the angiotensin antagonist DuP 753 on the renal adaptation to sodium restriction in the rat.
    Jover B; Dupont M; Nafrialdi E; Mimran A
    J Hypertens Suppl; 1991 Dec; 9(6):S210-1. PubMed ID: 1818949
    [No Abstract]   [Full Text] [Related]  

  • 22. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB; Smith RD
    Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M; Brunner HR
    Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of losartan on short-term variability of blood pressure of renovascular hypertensive rats: a spectral study.
    Ponchon P; Grichois ML; Elghozi JL
    J Hypertens Suppl; 1993 Dec; 11(5):S244-5. PubMed ID: 8158366
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The future role of losartan.
    Hansson L
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S55-8. PubMed ID: 8583483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog].
    Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW
    Arch Mal Coeur Vaiss; 1994 Aug; 87(8):971-4. PubMed ID: 7755474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates.
    DeGraaf GL; Pals DT; Couch SJ; Lawson JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):6-10. PubMed ID: 8423551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sympathetic and angiotensin-aldosterone systems on renal salt conservation in the rat.
    Honrath U; Veress AT; Chong CK; Sonnenberg H
    Am J Physiol; 1997 Apr; 272(4 Pt 2):F538-44. PubMed ID: 9140056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How well have animal studies with losartan predicted responses in humans?
    Sweet CS; Nelson EB
    J Hypertens Suppl; 1993 Apr; 11(3):S63-7. PubMed ID: 8315522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nonpeptide angiotensin II antagonists].
    Shionoiri H; Takasaki I; Sugimoto K; Minamisawa K
    Nihon Rinsho; 1992 Apr; 50 Suppl():753-63. PubMed ID: 1635263
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulation of ANG II receptor in hypertension: role of ANG II.
    Wang DH; Yao A; Zhao H; DiPette DJ
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H120-5. PubMed ID: 8760166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
    Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
    J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of cardiac hypertrophy and myosin isoenzyme patterns by losartan and captopril in renovascular hypertensive rats.
    Ling Q; Guo ZG; Su Z; Guo X
    Zhongguo Yao Li Xue Bao; 1994 May; 15(3):206-10. PubMed ID: 7976371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.
    Hirawa N; Uehara Y; Kawabata Y; Ohshima N; Ono H; Nagata T; Gomi T; Ikeda T; Goto A; Yagi S
    J Hypertens; 1994 Aug; 12(8):909-18. PubMed ID: 7814850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation.
    Vázquez E; Coronel I; Bautista R; Romo E; Villalón CM; Avila-Casado MC; Soto V; Escalante B
    Am J Physiol Renal Physiol; 2005 Jan; 288(1):F207-13. PubMed ID: 15367388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of chronic treatment with losartan potassium (DuP 753) on the elevation of blood pressure during chronic exposure of rats to cold.
    Fregly MJ; Rossi F; Van Bergen P; Brummermann M; Cade JR
    Pharmacology; 1993 Apr; 46(4):198-205. PubMed ID: 8483966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of pressure natriuresis by long-term losartan in spontaneously hypertensive rats.
    Kline RL; Liu F
    Hypertension; 1994 Oct; 24(4):467-73. PubMed ID: 8088913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model.
    Fujihara CK; Malheiros DM; Zatz R
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1810-8. PubMed ID: 17344184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Losartan improves baroreflex control of heart rate of coarcted hypertensive rats.
    Santos CM; Pontieri V; Leomil Neto M; Michelini LC
    Am J Physiol; 1995 Sep; 269(3 Pt 2):H812-8. PubMed ID: 7573522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.